Topic

breast cancer

13 articles

DOH names 3 breast cancer centres: what Dubai patients should check before referral

Dubai patients get a clearer Abu Dhabi referral route. Check screening age, insurance approval and licensed oncology options first.

10 Oct 2026 · 3 min read

DOH names 3 breast cancer centres: what Dubai patients should check before referral

Breaking

DOH names 3 Abu Dhabi breast cancer centres as oncology CoEs

DOH Abu Dhabi named 3 breast cancer CoEs. UAE clinics and insurers should review referral routes, authorisation rules and oncology capacity.

10 Oct 2026 · 3 min read

DOH names 3 Abu Dhabi breast cancer centres as oncology CoEs

Abu Dhabi breast cancer screenings rose 377.5% in October 2025

Abu Dhabi’s October screening surge gives UAE clinics a demand signal. Operators, insurers and patients need capacity, eligibility and price clarity.

9 Oct 2026 · 3 min read

Abu Dhabi breast cancer screenings rose 377.5% in October 2025

DHA’s age-40 mammogram rule puts symptom-free breast cancer screening back on clinic agendas

UAE doctors warn that breast cancer can be present without a lump. Clinics and insurers need clear recall, pricing and coverage workflows.

7 Oct 2026 · 3 min read

DHA’s age-40 mammogram rule puts symptom-free breast cancer screening back on clinic agendas

DHA screening starts at 40: what Dubai patients should do after a benign breast lump

A practical Dubai guide to breast lumps, mammograms, biopsy timing, insurance checks and licensed oncology care in the UAE.

5 Oct 2026 · 3 min read

DHA screening starts at 40: what Dubai patients should do after a benign breast lump

Emirates Cancer Association offers free mammograms for women 40+ at Al Ain Hope Walk

The Al Ain event shows how Pink October can convert awareness into screening volume. Clinics and insurers should prepare for demand.

3 Oct 2026 · 3 min read

Emirates Cancer Association offers free mammograms for women 40+ at Al Ain Hope Walk

Burjeel sends mobile mammography truck to dozens of Abu Dhabi sites in October 2026

Burjeel Cancer Institute is taking mammography into Abu Dhabi workplaces and malls. Clinics, insurers and patients should watch access, pricing and referrals.

1 Oct 2026 · 3 min read

Burjeel sends mobile mammography truck to dozens of Abu Dhabi sites in October 2026

Sharjah Ladies Club starts 9-hour breast checks as Pink October opens

Sharjah Ladies Club is offering free breast checks on 1 October. Clinics and insurers should watch conversion from awareness to booked imaging.

30 Sept 2026 · 3 min read

Sharjah Ladies Club starts 9-hour breast checks as Pink October opens

Pink Caravan 2026 adds 9 UAE breast screening clinics from 1 October

Pink Caravan returns on 1 October with free checks across the UAE. Clinics, insurers and patients need to plan for follow-up demand.

24 Sept 2026 · 3 min read

Pink Caravan 2026 adds 9 UAE breast screening clinics from 1 October

17-year-old Dubai student builds CareCheck AI for breast cancer awareness

Saiyette Aima built CareCheck after a family loss. UAE clinics can use the story to tighten screening pathways, AI governance and payer checks.

9 Sept 2026 · 3 min read

17-year-old Dubai student builds CareCheck AI for breast cancer awareness

Saiyette Aima’s CareCheck shows where UAE breast-health AI may fit. Clinics, insurers and patients need clear triage, validation and referral rules.

8 Sept 2026 · 3 min read

Regulatory & Policy

Burjeel treats first Camizestrant patient after UAE approval

Burjeel Cancer Institute gave Camizestrant to the world’s first clinical-care patient on 17 June 2026, six days after UAE approval.

17 Jun 2026 · 3 min read

Burjeel treats first Camizestrant patient after UAE approval

Regulatory & Policy

EDE clears AstraZeneca Etcamah after 55% PFS risk cut, ahead of FDA decision

EDE’s Etcamah approval gives UAE oncology leaders a 2026 formulary and testing decision: whether to fund serial ESR1 monitoring before radiographic progression.

11 Jun 2026 · 3 min read

EDE clears AstraZeneca Etcamah after 55% PFS risk cut, ahead of FDA decision